RVMD

40.16

0.32% -0.13

Pre-mercato: 41.39 1.23 +3.06%

Revolution Medicines Inc (RVMD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché RVMD Giù? Forum Previsione

Precedente Chiudi:

$40.29

Aprire:

$40.5

Volume 24 ore:

1.71M

Relative Volume:

1.08

Capitalizzazione di mercato:

$7.42B

Reddito:

$29.52M

Utile/perdita netta:

$-567.06M

Rapporto P/E:

-10.97

EPS:

-3.66

Flusso di cassa netto:

$-551.11M

1 W Prestazione:

+0.83%

1M Prestazione:

-8.85%

6M Prestazione:

-12.96%

1 anno Prestazione:

+49.13%

Intervallo 1D:

$39.36

$40.59

Intervallo di 1 settimana:

$39.36

$41.40

Portata 52W:

$26.56

$62.40

Revolution Medicines Inc Stock (RVMD) Company Profile

Nome

Revolution Medicines Inc

Settore

Healthcare (1176)

Industria

Biotechnology (685)

Telefono

415-766-3638

Indirizzo

700 SAGINAW DR, REDWOOD CITY, CA

Dipendente

490

Cinguettio

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

RVMD's Discussions on Twitter

Confronta RVMD con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
RVMD Revolution Medicines Inc	40.16	7.42B	29.52M	-567.06M	-551.11M	-3.66
VRTX Vertex Pharmaceuticals Inc	427.89	110.19B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	687.80	75.58B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	647.39	38.71B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	264.99	34.18B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.25	28.11B	3.30B	-501.07M	1.03B	-2.1146

Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-07-16	Reiterato	Needham	Buy
2024-07-12	Iniziato	Barclays	Overweight
2024-07-08	Iniziato	Jefferies	Buy
2024-04-12	Reiterato	Needham	Buy
2024-04-10	Aggiornamento	Raymond James	Outperform → Strong Buy
2024-03-11	Iniziato	Piper Sandler	Overweight
2024-01-05	Aggiornamento	BofA Securities	Neutral → Buy
2024-01-04	Iniziato	Wedbush	Outperform
2023-11-16	Iniziato	Raymond James	Outperform
2023-02-28	Aggiornamento	JP Morgan	Neutral → Overweight
2022-12-14	Iniziato	Needham	Buy
2022-10-21	Iniziato	Oppenheimer	Outperform
2022-05-20	Iniziato	BofA Securities	Neutral
2022-03-01	Aggiornamento	Stifel	Hold → Buy
2021-09-23	Iniziato	Stifel	Hold
2021-08-12	Downgrade	Goldman	Buy → Neutral
2021-05-18	Iniziato	Goldman	Buy
2020-05-21	Iniziato	H.C. Wainwright	Buy
2020-03-09	Iniziato	Cowen	Outperform
2020-03-09	Iniziato	Guggenheim	Buy
2020-03-09	Iniziato	JP Morgan	Neutral

Mostra tutto

Revolution Medicines Inc Borsa (RVMD) Ultime notizie

Jan 19, 2025

Sandy Cove Advisors LLC Acquires Shares of 42,008 Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Jan 19, 2025

Jan 18, 2025

Down -7.83% in 4 Weeks, Here's Why Revolution Medicines (RVMD) Looks Ripe for a Turnaround - MSN

Jan 18, 2025

Is Revolution Medicines, Inc. (RVMD) the Best Russell 2000 Stock to Invest in According to Analysts? - Insider Monkey

Jan 18, 2025

Revolution Medicines' SWOT analysis: stock poised for growth amid clinical trials - MSN

Jan 18, 2025

Jan 17, 2025

Certain Restricted Stock Units of Revolution Medicines, Inc. are subject to a Lock-Up Agreement Ending on 18-JAN-2025. - Marketscreener.com

Jan 17, 2025

Revolution Medicines (RVMD) Loses -7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN

Jan 17, 2025

Revolution Medicines (NASDAQ:RVMD) Trading Down 4.6%Should You Sell? - MarketBeat

Jan 17, 2025

(RVMD) Trading Advice - Stock Traders Daily

Jan 17, 2025